Rapid Acting Therapies

Nasal Drug Delivery Market Trends Point to $129 Billion Valuation by 2030

The global nasal drug delivery technology market is anticipated to reach a value of $129.23 billion by 2030, expanding at a compound annual growth rate of 8.8%. This growth is fueled by increased funding for CNS drug development, a rising need for rapid-acting therapies, and intensified research into nasal vaccines.